| dc.contributor.author | Yılmaz, Yusuf | |
| dc.contributor.author | Younossi, Zobair | |
| dc.date.accessioned | 2023-08-28T11:22:24Z | |
| dc.date.available | 2023-08-28T11:22:24Z | |
| dc.date.issued | 2023 | en_US |
| dc.identifier.citation | Yilmaz, Y., & Younossi, Z. (2023). Editorial: changes of health-related quality of life associated with hepatic disease severity and its improvement after treatment in NAFLD-authors' reply. Alimentary pharmacology & therapeutics, 57(2), 259–260. https://doi.org/10.1111/apt.17325 | en_US |
| dc.identifier.issn | 0269-2813 | |
| dc.identifier.issn | 1365-2036 | |
| dc.identifier.uri | https://doi.org/10.1111/apt.17325 | |
| dc.identifier.uri | https://hdl.handle.net/11436/8166 | |
| dc.description.abstract | We appreciate the editorial comments by Drs. Sun and Fan about our study assessing the associations of patient-reported outcomes (PROs) and non-invasive tests (NITs) in patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Wiley | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Liver disease | en_US |
| dc.title | Editorial: changes of health-related quality of life associated with hepatic disease severity and its improvement after treatment in NAFLD-authors' reply | en_US |
| dc.type | editorial | en_US |
| dc.contributor.department | RTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
| dc.contributor.institutionauthor | Yılmaz, Yusuf | |
| dc.identifier.doi | 10.1111/apt.17325 | en_US |
| dc.identifier.volume | 57 | en_US |
| dc.identifier.issue | 2 | en_US |
| dc.identifier.startpage | 259 | en_US |
| dc.identifier.endpage | 260 | en_US |
| dc.relation.journal | Alimentary Pharmacology & Therapeutics | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
